Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

Cornerstone Pharmaceuticals · 2009
ClinicalTrials.gov · Datasets · License: Public Domain · 2009
Open Source ↗
cancerpancreatic-cancer
cancer, pancreatic cancer, pancreatic carcinoma, cornerstone pharmaceuticals, inc., cpi-613, altered energy metabolism directed compound, phase i, phase ii, carcinoma of the pancreas, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1010546
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.